Stock Track | ResMed Soars 5.61% in After-Hours Trading on Strong Q2 Earnings Beat

Stock Track

Jan 30

ResMed Inc. (RMD) shares surged 5.61% during the after-hours session on Thursday following the release of the company's better-than-expected fiscal second-quarter results.

The medical device maker reported adjusted earnings per share of $2.81, exceeding analyst estimates of $2.72, while revenue grew 11% year-over-year to $1.42 billion, also beating expectations. The strong performance was driven by robust demand for ResMed's sleep apnea and respiratory care devices, with the company noting that gross margin expanded to 62.3% due to manufacturing efficiencies and component cost improvements.

Additionally, ResMed announced a quarterly cash dividend of $0.60 per share and reported repurchasing 704,000 shares for $175 million during the quarter. CEO Mick Farrell expressed confidence in the company's growth trajectory, stating that ResMed will continue to invest in innovation to scale digital health capabilities while delivering sustainable, profitable growth in the second half of fiscal 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1182855936"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1182855936\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1182855936?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-30 07:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182855936","market":"sg","top_or_hot":-1,"title":"Stock Track | ResMed Soars 5.61% in After-Hours Trading on Strong Q2 Earnings Beat","media":"Stock Track","content":"<p>ResMed Inc. (RMD) shares surged 5.61% during the after-hours session on Thursday following the release of the company's better-than-expected fiscal second-quarter results.</p><p>The medical device maker reported adjusted earnings per share of $2.81, exceeding analyst estimates of $2.72, while revenue grew 11% year-over-year to $1.42 billion, also beating expectations. The strong performance was driven by robust demand for ResMed's sleep apnea and respiratory care devices, with the company noting that gross margin expanded to 62.3% due to manufacturing efficiencies and component cost improvements.</p><p>Additionally, ResMed announced a quarterly cash dividend of $0.60 per share and reported repurchasing 704,000 shares for $175 million during the quarter. CEO Mick Farrell expressed confidence in the company's growth trajectory, stating that ResMed will continue to invest in innovation to scale digital health capabilities while delivering sustainable, profitable growth in the second half of fiscal 2026.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | ResMed Soars 5.61% in After-Hours Trading on Strong Q2 Earnings Beat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | ResMed Soars 5.61% in After-Hours Trading on Strong Q2 Earnings Beat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-01-30 07:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ResMed Inc. (RMD) shares surged 5.61% during the after-hours session on Thursday following the release of the company's better-than-expected fiscal second-quarter results.</p><p>The medical device maker reported adjusted earnings per share of $2.81, exceeding analyst estimates of $2.72, while revenue grew 11% year-over-year to $1.42 billion, also beating expectations. The strong performance was driven by robust demand for ResMed's sleep apnea and respiratory care devices, with the company noting that gross margin expanded to 62.3% due to manufacturing efficiencies and component cost improvements.</p><p>Additionally, ResMed announced a quarterly cash dividend of $0.60 per share and reported repurchasing 704,000 shares for $175 million during the quarter. CEO Mick Farrell expressed confidence in the company's growth trajectory, stating that ResMed will continue to invest in innovation to scale digital health capabilities while delivering sustainable, profitable growth in the second half of fiscal 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RMD","symbol_name":"瑞思迈","start_time":0,"source_url":"","article_id":"1182855936","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182855936","pubTimestamp":1769727830,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"ResMed Inc. (RMD) shares surged 5.61% during the after-hours session on Thursday following the release of the company's better-than-expected fiscal second-quarter results.The medical device maker...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RMD":"瑞思迈"},"translate_title":"股票追踪|瑞思迈(ResMed)盘后交易飙升5.61%，因第二季度盈利强劲","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RMD":1},"content_text":"ResMed Inc. (RMD) shares surged 5.61% during the after-hours session on Thursday following the release of the company's better-than-expected fiscal second-quarter results.The medical device maker reported adjusted earnings per share of $2.81, exceeding analyst estimates of $2.72, while revenue grew 11% year-over-year to $1.42 billion, also beating expectations. The strong performance was driven by robust demand for ResMed's sleep apnea and respiratory care devices, with the company noting that gross margin expanded to 62.3% due to manufacturing efficiencies and component cost improvements.Additionally, ResMed announced a quarterly cash dividend of $0.60 per share and reported repurchasing 704,000 shares for $175 million during the quarter. CEO Mick Farrell expressed confidence in the company's growth trajectory, stating that ResMed will continue to invest in innovation to scale digital health capabilities while delivering sustainable, profitable growth in the second half of fiscal 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}